Metraipolis › archive › dc_32c151bce33e
Ripk2 promotes CD8+ T cell inactivation and hepatocellular carcinoma progression through Myb/Cxcl9 and Pax5/Adpgk signaling pathways — Europe PMC PMID:42215445
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42215445
- DOI
- 10.1038/s41419-[numero omesso]-0
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T16:17:14.977Z
- SHA-256 of the archived text
9ac2fa77f34e651acb7302f60c641f7614eb4221a3cae175be071431d35fb476- Stable URL of this page
https://metraipolis.com/documento/dc_32c151bce33e
How to cite
Ripk2 promotes CD8+ T cell inactivation and hepatocellular carcinoma progression through Myb/Cxcl9 and Pax5/Adpgk signaling pathways — Europe PMC PMID:42215445 — Europe PMC (en), https://europepmc.org/article/MED/42215445 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_32c151bce33e (Metraipolis archive dc_32c151bce33e, sha256 9ac2fa77f34e651acb7302f60c641f7614eb4221a3cae175be071431d35fb476)
BibTeX
@misc{dc32c151bce33e,
title = {Ripk2 promotes CD8+ T cell inactivation and hepatocellular carcinoma progression through Myb/Cxcl9 and Pax5/Adpgk signaling pathways — Europe PMC PMID:42215445},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42215445},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_32c151bce33e; sha256 9ac2fa77f34e651acb7302f60c641f7614eb4221a3cae175be071431d35fb476},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42215445. Agents can read the archived copy with the MCP tool read_document.